15 Výsledek
FIELD OF THE INVENTION
The present invention generally relates to the prevention and treatment of inflammatory conditions and infections.
BACKGROUND
The following description includes information that may be useful in understanding the present invention. It is not an admission that any of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed, in part, to the discovery that valienamine-related disaccharide compounds reduce, in vivo, the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed, in part, to the discovery that valienamine-related disaccharide compounds reduce, in vivo, the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of inflammation and carbohydrate and glycoprotein chemistry. More specifically, the present invention relates to novel disaccharide inhibitors of inflammation.
2. Description of the Related
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to compounds, pharmaceutical compositions, and methods for treating or alleviating the symptoms of inflammation such as, for example, asthma.
2. Summary of the Related Art
Inflammation is a multi-focal host response to
The present invention relates to galactosylated pro-drugs of non-steroidal anti-inflammatories with free acid function and the process of synthesis thereof, which enables minimization of the gastrointestinal toxicity of the starting anti-inflammatory by means of esterification of its carboxylic
TECHNICAL FIELD
The present invention relates to a chondroitin sulfate (CS) with an extremely low and narrowly distributed molecular weight (1000-5000 daltons, polydispersity ranging from 1.1 to 1.3) produced by chemical sulfation of an unsulfated chondroitin backbone obtained with biotechnology
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydro/organo gelators, and more particularly, the present invention relates to a method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery,
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to hydro/organo gelators, and more particularly, the present invention relates to a method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery,
The present invention relates to novel disaccharides, the solvates and pharmaceutically acceptable salts thereof, and to the pharmaceutical compositions containing them. This invention also refers to a process for preparing the novel disaccharides, as well as to the therapeutical use thereof.
STATE
This is the U.S. national stage entry under 35 U.S.C. .sctn. 371 of PCT/GB94/00088, filed Jan. 19, 1994.
FIELD OF THE INVENTION
This invention relates to a series of carbohydrate-based compounds which are useful as anti-inflammatory agents and as agents for the control of tumour metastasis, to the
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target